Jos A. H. van Oers

Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial

Lore Vanderbeke, Nico Janssen, Dennis C. J. J. Bergmans et al. · Intensive Care Medicine · 2021 · 98 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Endothelium-associated biomarkers mid-regional proadrenomedullin and C-terminal proendothelin-1 have good ability to predict 28-day mortality in critically ill patients with SARS-CoV-2 pneumonia: A prospective cohort study

Jos A. H. van Oers, Yvette Kluiters, Judith Bons et al. · Journal of Critical Care · 2021 · 28 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Diagnostic Accuracy of Procalcitonin and C-reactive Protein Is Insufficient to Predict Proven Infection: A Retrospective Cohort Study in Critically Ill Patients Fulfilling the Sepsis-3 Criteria

Jos A. H. van Oers, Evelien de Jong, Hans Kemperman et al. · The Journal of Applied Laboratory Medicine · 2019 · 19 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +17

Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update

Fabian Termorshuizen, Dave A. Dongelmans, Sylvia Brinkman et al. · Annals of Intensive Care · 2024 · 17 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +13

Obesity May Not Be Associated with 28-Day Mortality, Duration of Invasive Mechanical Ventilation and Length of Intensive Care Unit and Hospital Stay in Critically Ill Patients with Severe Acute Respiratory Syndrome Coronavirus-2: A Retrospective Cohort Study

Sjaak Pouwels, Dharmanand Ramnarain, Emily Aupers et al. · Medicina · 2021 · 15 citations · Full text

Medicine, Infectious Diseases, Critical Care Medicine +16